Raftery M, Burke K, Murray N, O'Duinn O, Murray I, Hallahan B
1Galway Roscommon Mental Health Services, Roscommon Primary Care Centre,Roscommon,Ireland.
3Department of Psychology,Health Service Executive West, Mental Health Services,Claremorris, Co. Mayo,Ireland.
Ir J Psychol Med. 2017 Jun;34(2):99-109. doi: 10.1017/ipm.2016.19.
To evaluate the clinical benefits and associated cost effectiveness of an intensive personalised support (IPS) approach for clients suffering from psychosis and co-morbid mild intellectual disability (ID).
Four individuals with a psychotic disorder and co-morbid mild ID participated in an 18-month IPS rehabilitative intervention. Biopsychosocial measures were used to evaluate clinical effectiveness. A cost analysis was undertaken to examine the cost effectiveness of the intervention.
Reductions in psychopathology including anxiety symptoms were noted in all individuals. In addition, increased functioning and quality of life were demonstrated in all cases. Overall cost reductions were noted in inpatient care, accommodation and legal/emergency expenses.
The IPS approach was clinically effective particularly in addressing individual's psychosocial needs, psychological functioning, daily living skills and overall quality of life. Costs had decreased for three of the four individuals, ranging from a 17% to 46% savings. The findings highlight that the intervention was cost effective in most cases at this early stage. However, further research is necessary in order to ascertain if cost savings occur over time.
评估针对患有精神病和合并轻度智力残疾（ID）的患者采用强化个性化支持（IPS）方法的临床益处及相关成本效益。
四名患有精神障碍和合并轻度ID的个体参与了为期18个月的IPS康复干预。采用生物心理社会测量方法评估临床效果。进行成本分析以检验干预措施的成本效益。
所有个体的精神病理学症状包括焦虑症状均有所减轻。此外，所有病例的功能和生活质量均有所提高。住院护理、住宿以及法律/紧急费用方面总体成本有所降低。
IPS方法在临床上是有效的，尤其在满足个体的心理社会需求、心理功能、日常生活技能和总体生活质量方面。四名个体中有三名成本有所降低，节省幅度在17%至46%之间。研究结果表明，在这个早期阶段，该干预措施在大多数情况下具有成本效益。然而，有必要进行进一步研究以确定随着时间推移是否会节省成本。
